HealthBank posts FY2025 net loss of RMB3.3 million (60%)

Reuters
昨天
HealthBank posts FY2025 net loss of RMB3.3 million (60%)

HealthBank (HealthBank Holdings Ltd.) reported FY2025 revenue of CNY 0.14 million (26% YoY) and a net loss of CNY 3.29 million (60% YoY), according to its unaudited results for the year ended 31 December 2025. For 2HY25, revenue was CNY 0.11 million (26% YoY) and net loss was CNY 2.27 million (67% YoY). The FY2025 loss attributable to equity holders was CNY 3.23 million (60% YoY), with basic/diluted loss per share of 3.37 RMB cents (FY2025). As at 31 December 2025, HealthBank reported cash and bank balances of CNY 1.68 million, financial assets at fair value through profit or loss (FVTPL) of CNY 13.16 million, total assets of CNY 15.00 million, total liabilities of CNY 0.93 million and net assets of CNY 14.07 million. NAV per share was RMB 0.14 (31-Dec-25). Management said FY2025 revenue was generated from ad hoc consulting services provided by Hainan Zhongyuan Cultural Tourism Co., Ltd., and the revenue decline was attributed to reduced consulting work. Other income rose to CNY 0.12 million (more than 2x YoY), mainly due to reimbursement for Government-Paid Maternity Leave. Other losses were mainly driven by a CNY 1.46 million fair value loss on FVTPL. The group also highlighted a share placement: 7.75 million new shares were issued in October 2025 (Tranche 1), and a further 7.75 million shares were issued on 19 January 2026 (Tranche 2), taking issued shares to 109.80 million as at the announcement date; net proceeds from the placement were SGD 0.41 million, with SGD 0.15 million utilised as of the announcement date for working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthBank Holdings Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 5I2KB23I1ITUHI4E) on February 26, 2026, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10